Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.

<h4>Background</h4>Patients with chronic lymphocytic leukemia and 13q deletion as their only FISH abnormality could have a different outcome depending on the number of cells displaying this aberration. Thus, cases with a high number of 13q- cells (13q-H) had both shorter overall survival...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ana Eugenia Rodríguez, Jose Ángel Hernández, Rocío Benito, Norma C Gutiérrez, Juan Luis García, María Hernández-Sánchez, Alberto Risueño, M Eugenia Sarasquete, Encarna Fermiñán, Rosa Fisac, Alfonso García de Coca, Guillermo Martín-Núñez, Natalia de Las Heras, Isabel Recio, Oliver Gutiérrez, Javier De Las Rivas, Marcos González, Jesús M Hernández-Rivas
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c161b0b94cb74f61ad313f1a2d603024
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c161b0b94cb74f61ad313f1a2d603024
record_format dspace
spelling oai:doaj.org-article:c161b0b94cb74f61ad313f1a2d6030242021-11-18T08:09:02ZMolecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.1932-620310.1371/journal.pone.0048485https://doaj.org/article/c161b0b94cb74f61ad313f1a2d6030242012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23152777/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Patients with chronic lymphocytic leukemia and 13q deletion as their only FISH abnormality could have a different outcome depending on the number of cells displaying this aberration. Thus, cases with a high number of 13q- cells (13q-H) had both shorter overall survival and time to first therapy. The goal of the study was to analyze the genetic profile of 13q-H patients.<h4>Design and methods</h4>A total of 102 samples were studied, 32 of which served as a validation cohort and five were healthy donors.<h4>Results</h4>Chronic lymphocytic leukemia patients with higher percentages of 13q- cells (>80%) showed a different level of gene expression as compared to patients with lower percentages (<80%, 13q-L). This deregulation affected genes involved in apoptosis and proliferation (BCR and NFkB signaling), leading to increased proliferation and decreased apoptosis in 13q-H patients. Deregulation of several microRNAs, such as miR-15a, miR-155, miR-29a and miR-223, was also observed in these patients. In addition, our study also suggests that the gene expression pattern of 13q-H cases could be similar to the patients with 11q- or 17p-.<h4>Conclusions</h4>This study provides new evidence regarding the heterogeneity of 13q deletion in chronic lymphocytic leukemia patients, showing that apoptosis, proliferation as well as miRNA regulation are involved in cases with higher percentages of 13q- cells.Ana Eugenia RodríguezJose Ángel HernándezRocío BenitoNorma C GutiérrezJuan Luis GarcíaMaría Hernández-SánchezAlberto RisueñoM Eugenia SarasqueteEncarna FermiñánRosa FisacAlfonso García de CocaGuillermo Martín-NúñezNatalia de Las HerasIsabel RecioOliver GutiérrezJavier De Las RivasMarcos GonzálezJesús M Hernández-RivasJesús M Hernández-RivasPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 11, p e48485 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ana Eugenia Rodríguez
Jose Ángel Hernández
Rocío Benito
Norma C Gutiérrez
Juan Luis García
María Hernández-Sánchez
Alberto Risueño
M Eugenia Sarasquete
Encarna Fermiñán
Rosa Fisac
Alfonso García de Coca
Guillermo Martín-Núñez
Natalia de Las Heras
Isabel Recio
Oliver Gutiérrez
Javier De Las Rivas
Marcos González
Jesús M Hernández-Rivas
Jesús M Hernández-Rivas
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
description <h4>Background</h4>Patients with chronic lymphocytic leukemia and 13q deletion as their only FISH abnormality could have a different outcome depending on the number of cells displaying this aberration. Thus, cases with a high number of 13q- cells (13q-H) had both shorter overall survival and time to first therapy. The goal of the study was to analyze the genetic profile of 13q-H patients.<h4>Design and methods</h4>A total of 102 samples were studied, 32 of which served as a validation cohort and five were healthy donors.<h4>Results</h4>Chronic lymphocytic leukemia patients with higher percentages of 13q- cells (>80%) showed a different level of gene expression as compared to patients with lower percentages (<80%, 13q-L). This deregulation affected genes involved in apoptosis and proliferation (BCR and NFkB signaling), leading to increased proliferation and decreased apoptosis in 13q-H patients. Deregulation of several microRNAs, such as miR-15a, miR-155, miR-29a and miR-223, was also observed in these patients. In addition, our study also suggests that the gene expression pattern of 13q-H cases could be similar to the patients with 11q- or 17p-.<h4>Conclusions</h4>This study provides new evidence regarding the heterogeneity of 13q deletion in chronic lymphocytic leukemia patients, showing that apoptosis, proliferation as well as miRNA regulation are involved in cases with higher percentages of 13q- cells.
format article
author Ana Eugenia Rodríguez
Jose Ángel Hernández
Rocío Benito
Norma C Gutiérrez
Juan Luis García
María Hernández-Sánchez
Alberto Risueño
M Eugenia Sarasquete
Encarna Fermiñán
Rosa Fisac
Alfonso García de Coca
Guillermo Martín-Núñez
Natalia de Las Heras
Isabel Recio
Oliver Gutiérrez
Javier De Las Rivas
Marcos González
Jesús M Hernández-Rivas
Jesús M Hernández-Rivas
author_facet Ana Eugenia Rodríguez
Jose Ángel Hernández
Rocío Benito
Norma C Gutiérrez
Juan Luis García
María Hernández-Sánchez
Alberto Risueño
M Eugenia Sarasquete
Encarna Fermiñán
Rosa Fisac
Alfonso García de Coca
Guillermo Martín-Núñez
Natalia de Las Heras
Isabel Recio
Oliver Gutiérrez
Javier De Las Rivas
Marcos González
Jesús M Hernández-Rivas
Jesús M Hernández-Rivas
author_sort Ana Eugenia Rodríguez
title Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
title_short Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
title_full Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
title_fullStr Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
title_full_unstemmed Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
title_sort molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/c161b0b94cb74f61ad313f1a2d603024
work_keys_str_mv AT anaeugeniarodriguez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT joseangelhernandez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT rociobenito molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT normacgutierrez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT juanluisgarcia molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT mariahernandezsanchez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT albertorisueno molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT meugeniasarasquete molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT encarnaferminan molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT rosafisac molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT alfonsogarciadecoca molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT guillermomartinnunez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT nataliadelasheras molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT isabelrecio molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT olivergutierrez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT javierdelasrivas molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT marcosgonzalez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT jesusmhernandezrivas molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
AT jesusmhernandezrivas molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14
_version_ 1718422192003219456